UBS has given McDonald's a "Buy" rating and set a price target of $345 per share.
Analyst Dennis Geiger believes that the impact of recent E. coli cases on the company's revenue is uncertain. However, he is confident that McDonald's will take proactive measures to address any potential risks.
The report, released on October 23, 2024, discusses the ongoing challenges faced by the company and highlights its ability to navigate such issues. Investors are advised to closely monitor the situation as it develops.